Prognostic Factor Analysis of Stage 4S Neuroblastoma in Infant Patients: A Single Center Study

This retrospective study of 28 infants with stage 4S neuroblastoma identifies abdominal compartment syndrome and chemotherapy sensitivity as key prognostic factors, with an overall 5-year survival of 84.4%. The research provides insights into treatment approaches and outcomes for this unique metastatic disease category in infants.